Mood stabilizers in children and adolescents

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 38, Issue 5, 1999, Pages 529-536

  Ryan, Neal D ^a   Bhatara, Vinod S ^b   Perel, James M ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c NONE   (United States)

Author keywords

Bipolar disorder; Mood stabilizers; Psychopharmacology

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM ANTAGONIST; CARBAMAZEPINE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; NIMODIPINE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VERAPAMIL;

ADOLESCENT; ARTICLE; CHILD; CHILD PSYCHOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; MOOD; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

EID: 0032946771     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199905000-00014     Document Type: Article

References (99)

1. American Academy of Pediatrics Committee on Drugs (1995), Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics 96:538-540
2. Battino D, Estienne M, Avanzini G (1995a), Clinical pharmacokinetics of antiepileptic drugs in paediatric patients, part I: phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Clin Pharmacokinet 29:257-286
3. Battino D, Estienne M, Avanzini G (1995b), Clinical pharmacokinetics of antiepileptic drugs in paediatric patients, part II: phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate. Clin Pharmacokinet 29:341-369
4. Bhatara VS, Carrera J (1994), Medications for aggressiveness. J Am Aeod Child Adolesc Psychiatry 33:282-283
5. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J (1996), Childhood and adolescent depression: a review of the past 10 years. Part II. JAm Acad Child Adolesc Psychiatry 35:1575-1583
6. Botha JH, Gray AL, Miller R (1995), A model for estimating individualized valproate clearance values in children. J Clin Pharmacol 35:1020-1024
7. Bowden CL (1995), Predictors of response to divalproex and lithium. J Clin Psychiatry 56(suppl 3):25-30
8. Bowden CL, Brugger AM, Swann AC et al. (1994), Efficacy of divalproex vs lithium and placebo in the treatment of mania: the Depakote Mania Study Group. JAMA 271:918-924
9. Bowden CL, Janicak PG, Orsulak P et al. (1996), Relation of serum valproate concentration to response in mania. Am J Psychiatry 153:765-770
10. Bowring MA, Kovacs M (1992), Difficulties in diagnosing manic disorders among children and adolescents. J Am Acad Child Adolesc Psychiatry 31:611-614
11. Brouwer OF, Pieters MS, Edelbroek PM et al. (1992), Conventional and controlled release valproate in children with epilepsy: a cross-over study comparing plasma levels and cognitive performances. Epilepsy Res 13: 245-253
12. Brumback RA, Weinberg WA (1977), Mania in childhood, II: therapeutic trial of lithium carbonate and further description of manic-depressive illness in children. Am J Dis Child 131:1122-1126
13. Bryant AE III, Dreifuss FE (1996), Valproic acid hepatic fatalities, III: US experience since 1986. Neurology 46:465-469
14. Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ (1996a), Predictors of response to mood stabilizers. J Clin Psychopharmacol 16:24S-31S
15. Calabrese JR, Fatemi SH, Woyshville MJ (1996b), Antidepressant effects of lamotrigine in rapid cycling bipolar disorder (letter). Am J Psychiatry 153:1236
16. Camfield P, Hwang P, Camfield C, Fraser A, Soldin S, al-Quadah AK (1992), The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy. Can J Neural Sei 19:204-207
17. Campbell M, Adams PB, Small AM et al. (1995a), Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebocontrolled study. J Am Acad Child Adolesc Psychiatry 34:445-453 [published erratum appears in J Am Acad Child Adolesc Psychiatry 34:694, 1995]
18. Campbell M, Kafantaris V, Cueva JE (1995b), An update on the use of lithium carbonate in aggressive children and adolescents with conduct disorder. Psychopharmacol Bull 31:93-102
19. Campbell M, Silva RR, Kafantaris V et al. (1991), Predictors of side effects associated with lithium administration in children. Psychopharmacol Bull 27:373-380
20. Campbell M, Small AM, Green WH et al. (1984), Behavioral efficacy of haloperidol and lithium carbonate: a comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 41:650-656
21. Carlson GA, Davenport YB, Jamison K ( 1977), A comparison of outcome in adolescent- and later-onset bipolar manic-depressive illness. Am J Psychiatry 134:919-922
22. Cloyd JC, FischerJH, Kriel RL, Kraus DM (1993), Valproic acid pharmacokinetics in children, IV: effects of age and antiepileptic drugs on protein binding and intrinsic clearance. Clin Pharmacol Ther 53:22-29
23. Cornaggia C, Gianetti S, Battino D et al. (1993), Comparative pharmacokinetic study of chewable and conventional carbamazepine in children. Efilepsia 34:158-160
24. Cueva JE, Overall JE, Small AM, Armenteros JL, Perry R, Campbell M (1996), Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry 35:480-490
25. De Montigny C, Grunberg F, Mayer A, Deschenes JP (1981), Lithium induces rapid relief of depression in tricyclic antidepressant drug nonresponders. BrJPsychiatry 138:252-256
26. Deicken RF (1990), Verapamil treatment of bipolar depression. J Clin Psychopharmacol 10:148-149
27. DeLong GR, Aldershof AL (1987), Long-term experience with lithium treatment in childhood: correlation with clinical diagnosis. J Am Acad Child Adolesc Psychiatry 26:389-394
28. DeLong GR, Nieman GW (1983), Lithium-induced behavior changes in children with symptoms suggesting manic-depressive illness. Psychopharmacol Bull 19:258-265
29. Donovan SJ, Susser ES, Nuncs EV, Stewart JW, Quitkin FM, Klein DF (1997), Divalproex treatment of disruptive adolescents: a report of 10 cases.JClin Psychiatry 58:12-15
30. Eeg-Olofsson O, Nilsson HL, Tonnby B et al. (1990), Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: a comparison between conventional and slowrelease formulations. J Child AferoJ5:159-165
31. Elwes RD, Binnie CD (1996), Clinical pharmacokinetics of newer antiepileptic drugs: lamotrigine, vigabatrin, gabapentin and oxcarbazcpine. Clin Pharmacokinet 30:403-415
32. Garcia Belmonte MA, Pugliese AE (1970), Tratamiento del syndrome de hiperquinesia infantil concarbamacepina. El Dia Medico 41:759-760
33. Geller B, Cooper TB, Sun K et al. (1998), Double-blind and placebo controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. JAm Acad Child Adolesc Psychiatry 37:171-178
34. Giannini AJ, Loiselle RH (1996), Verapamil maintenance therapy in bipolar patients (letter). J Clin Psychiatry 57:136
35. Goodnick PJ (1995), Nimodipine treatment of rapid cycling bipolar disorder (letter). J Clin Psychiatry 56:330
36. Greenhill LL, Rieder RO, Wender PH, Buchsbaum M, Zhan TP (1973), Lithium carbonate in the treatment of hyperactive children. Arch Gen Psychiatry 28:636-640
37. Groh C, Roscmayr F, Birbaumer N (1971), Psychotrope Wirkung von carbamazepin bei night-epileptischen kindcrn. Med Monatsschr 25:329-333
38. Grunze H, Waiden J, Wolf R, Berger M (1996), Combined treatment with lithium and nimodipine in a bipolar I manic syndrome. Prog Neuropsychophannacol Biol Psychiatry 20:419-426
39. Hagino OR, Weller EB, Weller RA, Washing D, Fristad MA, Kontras SB (1995), Untoward effects of lithium treatment in children aged four through six years. JAm Acad Child Adolesc Psychiatry 34:1584-1590
40. Herranz JL, Armijo JA, Artega R (1988), Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy with children. Epilepsia 29:794-804
41. Hoschl C, VackovaJ, Janda B (1992), Mood stabilizing effect of verapamil. BratislLck Listy 93:208-209
42. Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla W (1993), Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. NEnglJMed329:1383-1388
43. Isojarvi JIT, Ratrya J, Myllyla W et al. (1998), Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neural43:446-451
44. Kafantaris V, Campbell M, Padron-Gayol MV, Small AM, Locascio JJ, Rosenberg CR (1992), Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study. Psychopharmacol Bull 28:193-199
45. Keck PE Jr, McEIroy SL,Tugrul KC, Bennett JA (1993), Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 54:305-308
46. Kovacs M, Pollock M (1995), Bipolar disorder and comorbid conduct disorder in childhood and adolescence. J Am Acad Child Adolesc Psychiatry 34:715-723
47. Kowatch RA, SuppesT, Gilfillan SK, Fuentes RM, Grannemann BD, Emslie GJ ( 1995), Clozapine treatment of children and adolescents with bipolar disorder and schizophrenia: a clinical case series. J Child Adolesc Psychopharmacol 5:241-253
48. Kriel RL, Fischer JH, Cloyd JC, Green KH, Fraser GL (1986), Valproic acid phaimacokinetics in children, III: very high dosage requirements. Pediatr Neural 2:202-208
49. Lenzi A, Marazziti D, Raffaelli S, Cassano GB (1995), Effectiveness of the combination verapamil and chlorpromazine in the treatment of severe manic or mixed patients. Prog Nturopsychopharmacol Biol Psychiatry 19:519-528
50. Liu H, Delgado MR (1994), A comprehensive study of the relation between serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites with age, weight, dose, and clearances in epileptic children. Epiltpsia 35:1221-1229
51. Malone RP, Delaney MA, Luebbert JF, White MA, Biesccker KA, Cooper TB (1995), The lithium test dose prediction method in aggressive children. Psychopharmacol Bull 31:379-382
52. McKnew DH, Cytryn L, Buchsbaum MS et al. (1981), Lithium in children of lithium-responding parents. Psychiatry Res 4:171-180
53. Milberger S, Biederman J, Faraone SV, Murphy J, Tsuang MT (1995), Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry 152:1793-1799
54. Myers WC, Carrera F III (1989), Carbamazepine-induced mania with hypersexuality in a 9-year-old boy (letter). Am J Psychiatry 146:400
55. Okuma T (1993), Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 27:138-145
56. Ostow M (1987), Verapamil and bipolar illness (letter). J Clin Psychopharmacol 7:277
57. Papatheodorou G, Kutcher SP (1993), Divalproex sodium treatment in late adolescent and young adult acute mania. PsychopharmacolBull 29:213-219
58. Pazzaglia PJ, Post RM, Ketter TA, George MS, Marangell LB (1993), Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatry Res 49:257-272
59. Pellock JM (1987), Carbamazepine side effects in children and adults. Epilepsia 28(suppl 3):S64-S70
60. Pleak RR, Birmaher B, Gavrilescu A, Abichandani C, Williams DT (1988), Mania and neuropsychiatrie excitation following carbamazepine. J Am Acad Child Adolesc Psychiatry 27:500-503
61. Post RM, Ketter TA, Denicoff K et al. (1996), The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 128:115-129
62. Pucnte RM, Barriga F, Morales MT (1973), Estudio doble-ciego con carbamazepina en un grupo de escolares con dano cerebral: comunicacion preliminar. Med Rev Mex 53:97-101
63. Reiss AL, O'Donnell DJ (1984), Carbamazepine-induced mania in two children: case report. J Clin Psychiatry 45:272-274
64. Rifkin A, Karajgi B, Dicker R et al. (1997), Lithium treatment of conduct disorders in adolescents. Am J Psychiatry 154:554-555
65. Rosenberg DR, Holttum J, Gershon S (1994), Textbook of Pharmacotherapy for Child and Adolescent Psychiatric Disorders. New York: Brunner/Mazel
66. Ryan ND, Meyer V, Dachille S, Mazzie D, Puig-Amich J (1988), Lithium antidepressant augmentation in TCA-refractory depression in adolescents. JAm Acad Child Adolesc Psychiatry 27:371-376
67. Schaffer CB, Schaffer LC (1997), Gabapentin in the treatment of bipolar disorder. Am J Psychiatry 154:291-292
68. Schiff HB, Sabin TD, Geller A, Alexander L, Mark V (1982), Lithium in aggressive behavior. Am J Psychiatry 139:1346-1348
69. Silberstein SD, Wilmore LJ (1996), Divalproex sodium: migraine treatment and monitoring. Headache 36:239-242
70. Silva RR, Campbell M, Golden RR, Small AM, Pataki CS, Rosenberg CR (1992), Side effects associated with lithium and placebo administration in aggressive children. Psychopharmacol Bull 28:319-326
71. Silva RR, Gonzalez N, Kafantaris V, Campbell M (1991), Long-term use of lithium in aggressive conduct disorder children. Presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, October
72. Silva RR, Munoz DM, Alpert M (1996), Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis. JAm Acad Child Adolesc Psychiatry 35:352-358
73. Solomon DA, Keitner GI, Ryan CE, Miller IW (1996), Polypharmacy in bipolar I disorder. Psychopharmacol Bull 32:579-587
74. Solomon DA, Ryan CE, Keitner GI et al. (1997), A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. J Clin Psychiatry 58:95-99
75. StantonSP, Keck PEJr, McElroy SL (1997), Treatment of acute mania with gabapentin (letter). Am J Psychiatry 154:287
76. Stoll AL, Banov M, Kolbrener M et al. (1994), Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders. J Clin Psychopharmacol 14:311-313
77. Strober M (1997), The naturalistic prospective course of juvenile bipolar illness. Presented at the Second International Conference on Bipolar Disorder, Pittsburgh, June 20
78. Strober M, Freeman R, Kigali J, Schmidt S, Diamond R (1992), The pharmacotherapy of depressive illness in adolescence, II: effects of lithium augmentation in nonresponders to imipramine. J Am Acad Child Adolesc Psychiatry 31:16-20
79. Strober M, Morrell W, Lampert C, Burroughs J (1990), Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am J Psychiatry 147:457-461
80. Stuppaeck C, Barnas C, Miller C, Schwitzer J, Fleischhacker WW (1990), Carbamazepine in the prophylaxis of mood disorders. J Clin Psychofharmacol 10:39-42
81. Sugimoto T, Muro H, Woo M, Nishida N, Murakami K (1996), Valproate metabolites in high-dose valproate plus phenytoin therapy. Efiltfsia 37:1200-1203
82. Suzuki Y, Cox S, HayesJ, WalsonPD (1991), Carbamazepine age-dose ratio relationship in children. TherDrugMonit 13:201-208
83. Swann AC, Bowden CL, Morris D et al. (1997), Depression during mania: treatment response to lithium or divalprocx. Arch Gen Psychiatry 54:37-42
84. Thakker KM, Mangat S, Garnett WR, Levy RH, Kochak GM (1992), Comparative bioavailability and steady state fluctuations of Tcgretol commercial and Carbamazepine OROS tablets in adult and pediatrie epileptic patients. Biophann Dnig Dispos 13:559-569
85. VarankaTM, Weller RA, Weller EB, Fristad MA (1988), Lithium treatment of manic episodes with psychotic features in prepubertal children. Am J Psychiatry 145:1557-1559
86. Vetro A, Szentistvanyi I, Pallag L, Vargha M, Szilard J (1985), Therapeutic experience with lithium in childhood aggressivity. Neuropsychobiology 14:121-127
87. Vitiello B, Behar D, Ryan P, Malone R, Delaney MA (1987), Saliva lithium monitoring. J Am Acad Child Adolesc Psychiatry 26:812-813
88. Wagner JG, Rocchini AP, Vasiliades J (1982), Prediction of steady-staten verapamil plasma concentrations in children and adults. Clin Pharmacol Thtr 32:172-181
89. Walden J, Hesslinger B, van Calker D, Berger M (1996), Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Phannacopsychiatry 29:193-195
90. Weller EB, Weller RA, Fristad MA, Cantwell M, Tucker S (1987), Saliva lithium monitoring in prepubertal children. J Am Acad Child Adolfsc Psychiatry 26:173-175
91. Weiner A, Weiner Z, Leonard MA (1977), Bipolar manic-depressive disorder: a reassessment of course and outcome. Compr Psychiatry 18:327-332
92. West SA, Keck PE, McElroy SL et al. (1994), Open trial of valproate in the treatment of adolescent mania. J Child Adolesc Psychopharmacol 4:263-267
93. West SA, Keck PEJ, McElroy SL (1995), Oral loading doses in the valproate treatment of adolescents with mixed bipolar disorder. J Child Adolesc Psychopharmacol 5:225-231
94. Whittier MC, West SA, Galli VB, Raute NJ (1995), Valproic acid for dysphoric mania in a mentally retarded adolescent. J Clin Psychiatry 56:590-591
95. Wozniak J, Biederman J, Mundy E, Mennin D, Faraone SV (1995), A pilot family study of childhood-onset mania. J Am Acad Child Adolesc Psychiatry 34:1577-1583
96. Youngerman J, Canino IA (1978), Lithium carbonate use in children and adolescents: a survey of the literature. Arch Gen Psychiatry 35:216-224
97. Yukawa E (1995), A feasibility study of the multiple-peak approach for pharmacokinetic screening: population-based investigation of valproic acid relative clearance using routine clinical pharmacokinetic data. J Pharm Pharmacol 47:1048-1052
98. Yukawa E, Aoyama T (1996), Detection of carbamazepine drug interaction by multiple peak approach screening using routine clinical pharmacokinetic data. J Clin Pharmacol 36:752-759
99. Zaccara G, Messori A, Moroni F (1988), Clinical pharmacokinetics of valproic acid-1988. Clin Pharmacokinet 15:367-389